{"transactions":[{"id":814158,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-06T20:15:08.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":197444,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001732369-26-000010","document":"form4-04062026_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000173236926000010/form4-04062026_040401.xml","form_type":"4"}},{"id":814157,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-06T20:15:08.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":true,"shares":55000,"price":0.3,"value":16500.0,"ownership":{"direct":true},"balance_after":440708,"source":{"system":"sec-edgar","filing":"0001732369-26-000010","document":"form4-04062026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000173236926000010/form4-04062026_040401.xml","form_type":"4"}},{"id":879242,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-26T21:15:24.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in one-fourth (1/4th) increments upon the closing price of the Issuer's common stock equaling or exceeding 125%, 150%, 175% and 200%, respectively, of the exercise price for 30 calendar days between February 24, 2026 and February 24, 2031, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":15.52,"expiration_date":"2036-02-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001732369-26-000008","document":"form4-02262026_040216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000173236926000008/form4-02262026_040216.xml","form_type":"4"}},{"id":879241,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-26T21:15:24.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":217000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option shall vest on February 24, 2027, and the remaining shares subject to the option shall vest in twelve substantially equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":217000,"derivative":{"exercise_price":15.52,"expiration_date":"2036-02-23","underlying":"Common Stock","underlying_shares":217000},"source":{"system":"sec-edgar","filing":"0001732369-26-000008","document":"form4-02262026_040216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000173236926000008/form4-02262026_040216.xml","form_type":"4"}},{"id":890171,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-02-20T21:15:17.000Z","date":"2026-02-19","kind":"sale","planned":false,"acquired":false,"shares":7015,"price":16.17,"value":113432.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":385708,"source":{"system":"sec-edgar","filing":"0001732369-26-000004","document":"form4-02202026_040207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000173236926000004/form4-02202026_040207.xml","form_type":"4"}},{"id":941789,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-09T21:15:05.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2024, the Reporting Person filed a Form 4 with the SEC reporting the grant of an option to purchase 125,000 shares of common stock, the vesting of which was subject to the achievement of specified performance criteria. On January 7, 2026, the Compensation Committee of the Issuer's Board of Directors certified that (i) certain performance condition with respect to the option to purchase 62,500 shares had been met, resulting in the immediate vesting of 31,250 shares and the vesting of 31,250 shares on December 31, 2026, subject to the continuous service of the Reporting Person through such date, and (ii) certain performance condition with respect to the option to purchase 62,500 shares had not been met, resulting in the forfeiture of such option for no consideration."}],"balance_after":62500,"derivative":{"exercise_price":63.61,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001732369-26-000002","document":"form4-01092026_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000173236926000002/form4-01092026_040101.xml","form_type":"4"}},{"id":1046642,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-09-05T20:10:08.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":90500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs vest as follows:  25% of the RSUs shall vest on each of February 18, 2026, February 18, 2027, February 18, 2028 and February 18, 2029, in each case, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":392723,"source":{"system":"sec-edgar","filing":"0001415889-25-023791","document":"form4-09052025_040903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000141588925023791/form4-09052025_040903.xml","form_type":"4"}},{"id":1176310,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-07T20:15:07.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":false,"shares":49367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":252444,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":49367},"source":{"system":"sec-edgar","filing":"0001415889-25-010290","document":"form4-04072025_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000141588925010290/form4-04072025_040401.xml","form_type":"4"}},{"id":1176309,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-04-07T20:15:07.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":true,"shares":49367,"price":0.3,"value":14810.1,"ownership":{"direct":true},"balance_after":302223,"source":{"system":"sec-edgar","filing":"0001415889-25-010290","document":"form4-04072025_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000141588925010290/form4-04072025_040401.xml","form_type":"4"}},{"id":1621682,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-23T22:07:02.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transaction involves the Reporting Person's receipt of an option grant. The shares subject to the option shall vest upon the achievement of specified performance criteria, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":125000,"derivative":{"exercise_price":63.61,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-24-005069","document":"form4-02232024_100242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000141588924005069/form4-02232024_100242.xml","form_type":"4"}},{"id":1640519,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-16T01:41:00.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 13, 2025, and 6.25% of the shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":125000,"derivative":{"exercise_price":56.18,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-24-004005","document":"form4-02162024_010254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000141588924004005/form4-02162024_010254.xml","form_type":"4"}},{"id":1921592,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-11T20:05:25.000Z","date":"2023-04-08","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":45087,"derivative":{"exercise_price":0.48,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-23-023991","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919123023991/doc4.xml","form_type":"4"}},{"id":1921591,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-11T20:05:25.000Z","date":"2023-04-08","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":0.48,"value":1920.0,"ownership":{"direct":true},"balance_after":252856,"source":{"system":"sec-edgar","filing":"0001209191-23-023991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919123023991/doc4.xml","form_type":"4"}},{"id":2006389,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-17T21:13:56.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 16, 2024, and 6.25% of the shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":54.38,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-010551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919123010551/doc4.xml","form_type":"4"}},{"id":2228490,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-17T12:28:16.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":0.26,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-072188","document":"tm2218714-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922072188/tm2218714-6_4seq1.xml","form_type":"4"}},{"id":2235305,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-10T20:12:01.000Z","date":"2022-06-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":8822,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-035848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919122035848/doc4.xml","form_type":"4"}},{"id":2235304,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-10T20:12:01.000Z","date":"2022-06-09","kind":"exercise","acquired":true,"shares":5000,"price":0.3,"value":1500.0,"ownership":{"direct":true},"balance_after":248856,"source":{"system":"sec-edgar","filing":"0001209191-22-035848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919122035848/doc4.xml","form_type":"4"}},{"id":2426345,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-25T21:17:29.000Z","date":"2022-01-21","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option shall vest on January 19, 2023, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":165000,"derivative":{"exercise_price":46.3,"expiration_date":"2032-01-20","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001209191-22-004771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919122004771/doc4.xml","form_type":"4"}},{"id":2703638,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T20:10:25.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 19, 2022 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":1.48,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-21-002610","document":"form4-05202021_040512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002610/form4-05202021_040512.xml","form_type":"4"}},{"id":2909041,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-12T22:20:32.000Z","date":"2021-01-10","kind":"grant","acquired":true,"shares":127200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option shall vest on January 7, 2022, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":127200,"derivative":{"exercise_price":70.93,"expiration_date":"2031-01-09","underlying":"Common Stock","underlying_shares":127200},"source":{"system":"sec-edgar","filing":"0001209191-21-003271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919121003271/doc4.xml","form_type":"4"}},{"id":3137701,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T20:10:52.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 20, 2021 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":3.39,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-20-001305","document":"form4-05222020_040537.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001305/form4-05222020_040537.xml","form_type":"4"}},{"id":3177609,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series C Preferred Stock","published_at":"2020-04-13T21:19:02.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":11169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11169},"source":{"system":"sec-edgar","filing":"0001209191-20-024232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919120024232/doc4.xml","form_type":"4"}},{"id":3177608,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-04-13T21:19:02.000Z","date":"2020-04-13","kind":"purchase","acquired":true,"shares":20000,"price":16,"value":320000.0,"ownership":{"direct":true},"balance_after":243856,"source":{"system":"sec-edgar","filing":"0001209191-20-024232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919120024232/doc4.xml","form_type":"4"}},{"id":3177607,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-04-13T21:19:02.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":11169,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."}],"balance_after":223856,"source":{"system":"sec-edgar","filing":"0001209191-20-024232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919120024232/doc4.xml","form_type":"4"}},{"id":3179471,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-09T01:03:33.000Z","date":"2020-04-07","kind":"grant","acquired":true,"shares":696569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option shall vest on March 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":696569,"derivative":{"exercise_price":16,"expiration_date":"2030-04-06","underlying":"Common Stock","underlying_shares":696569},"source":{"system":"sec-edgar","filing":"0001209191-20-023991","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664710/000120919120023991/doc4.xml","form_type":"4"}},{"id":3509118,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-29T21:10:56.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on May 29, 2020 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":9.02,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-19-000621","document":"form4-05292019_020542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000621/form4-05292019_020542.xml","form_type":"4"}},{"id":3889186,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":53564,"kind":"person","name":"Seehra Jasbir","position":1,"cik":"0001732369","reported_name":"Seehra Jasbir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T22:26:03.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on June 15, 2019 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":40000,"derivative":{"exercise_price":23.27,"expiration_date":"2028-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-038663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118038663/doc4.xml","form_type":"4"}}]}